Cornerstone Therapeutics (CRTX) Posts Surprise Q4 Loss of 6c/Share; Revs Light
Tweet
Share
E-mailGet Alerts CRTX Hot Sheet
Price: $1.95 --0%
Financial Fact:
Weighted-average common shares, diluted: 31.5M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Weighted-average common shares, diluted: 31.5M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q4 EPS of ($0.06), $0.15 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $18.21 million versus the consensus estimate of $24.58 million.
For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.
For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
